Invesaro

Stocks USFD Financial statements

Financial statements

US Foods Holding Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data US Foods Holding Corp. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue22,91924,14724,17525,93922,88529,48734,05735,59737,87739,424
Cost of revenue18,86619,92919,86921,35219,16624,83228,56529,44931,34332,560
Gross profit4,0534,2184,3064,5873,7194,6555,4926,1486,5346,864
Selling, general and administrative3,5813,6313,6473,8883,7574,2204,8865,1175,4125,632
Operating expenses3,6343,6303,6483,8883,7964,2314,8985,1315,4355,665
Operating income419588658699-774245941,0171,0991,199
Interest expense229170175184238213255324315305
Other non-operating income-5-1413-42126226-64
Pre-tax income131404496511-294214361678644898
Income tax-79-4089126-685096172150222
Income from continuing operations407385
Net income210444407385-226164265506494676
EBITDA8409669981,0613458029661,4121,5371,661
EPS, basic1.052.001.881.77-1.150.551.022.092.052.98
EPS, diluted1.031.971.871.75-1.150.541.012.022.022.94
Shares, basic (weighted)200223216218220222224239241227
Shares, diluted (weighted)204226218220220225226250244230

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents131119104908281482112695941
Receivables1,2261,3021,3471,4551,0841,4691,7051,8541,9572,026
Inventory1,2231,2081,2791,4321,2731,6861,6161,6001,6261,711
Other current assets9.7883032261819141160
Total current assets2,7892,8192,9793,2623,4653,5943,8204,0313,9744,164
Property, plant and equipment1,7681,8011,8422,0752,0212,0332,1712,2802,3982,681
Lease right-of-use assets145284275265290271332
Goodwill3,9083,9673,9674,7285,6375,6255,6255,6975,7665,794
Intangible assets387364324967892830785803836781
Other non-current assets57.96567256407431372376429523
Total assets8,9449,0379,18611,28812,42312,52112,77313,18713,43613,943
Accounts payable1,2951,2891,3591,4601,2181,6621,8552,0512,2312,447
Accrued liabilities157161454538497610650731732839
Short-term debt7610910614213195116110109137
Total current liabilities1,9692,0032,0762,3621,9822,5502,7963,1123,2963,591
Long-term debt3,7063,6483,3514,5945,6174,9164,7384,5644,8195,063
Lease liabilities21131263244246265248307
Other non-current liabilities351372232315505479446469447556
Total liabilities6,4076,2865,9577,5798,3748,2528,2788,4388,9089,636
Total debt3,8003,8003,4574,7365,7485,0114,8544,6744,9285,200
Paid-in capital2,7912,7202,7802,8452,9012,9703,0363,6633,7483,777
Retained earnings-1361245319166617821,0101,5092,0032,679
Treasury stock0-14-311-1,269-2,200
Other comprehensive income-119-95-84-54-34-19-73-1154348
Shareholders' equity2,5382,7513,2293,7093,5303,7353,9614,7494,5284,307
Total equity2,5382,7513,2293,7093,5303,7353,9614,7494,5284,307
Total liabilities and equity8,9449,0379,18611,28812,42312,52112,77313,18713,43613,943
Shares outstanding221215217220221223225245231221

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income210444407385-226164265506494676
Depreciation and amortization421378340362422378372395438462
Stock-based compensation18212832404845566383
Deferred income tax-80-123457-5138179-1086
Change in receivables22-67-71-19334-386-240-157-140-95
Change in inventory-10140-7216201-4137061-16-66
Cash from operations5497496097604134197651,1401,1741,369
Capital expenditures-164-221-235-258-189-274-265-309-341-410
Acquisitions-122-1820-1,832-97200-196-214-131
Purchases of investments-49300
Cash from investing-762-356-232-1,987-1,110-262-255-495-552-497
Debt issued001,0005000
Debt repaid00-1,000
Stock issued300193151526156
Share buybacks0-2800000-14-294-948-926
Cash from financing-180-405-3911,2201,427-837-447-587-831-890
Net change in cash-393-12-14-7730-6806358-209-18
Free cash flow385528374502224145500831833959
Interest paid223158160173216185243294284300
Income taxes paid51178137-116816118189

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $93.33 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin17.6%Gross profit / revenue.
Operating margin3.1%Operating income / revenue.
EBITDA margin4.2%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin2.4%Pre-tax income / revenue.
Net margin1.8%Net income / revenue.
FCF margin2.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin3.4%Cash from operations / revenue.
Effective tax rate24.2%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)17.0%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)5.1%Net income / average total assets.
Return on invested capital (ROIC)10.1%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue14.3%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.2%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.1%Capital expenditures / revenue.
D&A / revenue1.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y4.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y5.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y5.1%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y7.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y13.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y9.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y26.4%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y8.1%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y19.8%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y36.9%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y36.8%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y36.6%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y45.5%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y42.8%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y16.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y21.4%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y27.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y15.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y24.2%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y33.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-4.9%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y2.8%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y4.1%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y3.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y3.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y2.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-5.7%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.6%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.14xCurrent assets / current liabilities.
Quick ratio0.58x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.01x(Cash + short-term investments) / current liabilities.
Debt / equity1.22xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets36.5%Total debt / total assets.
Liabilities / assets70.2%Total liabilities / total assets.
Net debt$5.18BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA3.04xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage4.12xOperating income / interest expense.
Working capital$536.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets45.7%(Goodwill + intangible assets) / total assets.
Tangible book value-$2.27BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover2.80xRevenue / average total assets.
Fixed asset turnover14.8xRevenue / average property, plant and equipment.
Inventory turnover19.4xCost of revenue / average inventory.
Days inventory19 days365 x average inventory / cost of revenue.
Receivables turnover18.0xRevenue / average receivables.
Days sales outstanding20 days365 x average receivables / revenue.
Days payables31 days365 x average accounts payable / cost of revenue.
Cash conversion cycle8 daysDays inventory + days sales outstanding - days payables.
FCF conversion129.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow30.9%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$3.29Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$181.60Revenue / diluted weighted shares.
FCF per share$4.28Free cash flow / diluted weighted shares.
Operating cash flow per share$6.19Cash from operations / diluted weighted shares.
Book value per share$19.78Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$10.49Tangible book value / shares outstanding.
Cash per share$0.26(Cash + short-term investments) / shares outstanding.
Buybacks / FCF116.4%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$20.19BShare price x shares outstanding.
Enterprise value$25.37BMarket cap + total debt - cash - short-term investments.
P/E27.7xMarket cap / net income. Only when net income is positive.
P/S0.50xMarket cap / revenue.
P/B4.72xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF21.3xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF14.7xMarket cap / cash from operations, when positive.
EV/Sales0.63xEnterprise value / revenue.
EV/EBIT20.1xEnterprise value / operating income, when both are positive.
EV/EBITDA14.9xEnterprise value / EBITDA, when both are positive.
EV/FCF26.8xEnterprise value / free cash flow, when both are positive.
FCF yield4.7%Free cash flow / market cap.
Earnings yield3.6%Net income / market cap (the inverse of P/E).
Shareholder yield5.5%(Dividends paid + share buybacks) / market cap.
PEG0.65xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was US Foods Holding Corp.'s revenue in fiscal 2025?

US Foods Holding Corp. reported revenue of $39.42B for fiscal 2025, 4.1% higher than the year before.

Was US Foods Holding Corp. profitable in fiscal 2025?

Yes. Net income was $676.0M, a net margin of 1.7%.

How much free cash flow did US Foods Holding Corp. generate in fiscal 2025?

Cash from operations of $1.37B minus capital expenditures of $410.0M left free cash flow of $959.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to US Foods Holding Corp.